The SoPRano™ platform is broadly enabling and has been adapted for a variety of applications in basic research and pharmaceutical discovery and QC. Current applications include:
- Antibody-Antigen interactions:
- Affinity ranking;
- Epitope mapping;
- QC and product release.
- Protein-protein interaction assays:
- Concentration & KD determination through dose response curve.
- Small molecule protein-protein inhibition assays:
- Yes/No small molecule inhibition screening assays;
- Small molecule inhibition assays for hit confirmation & EC50 determination.
Additional applications, conjugation methods and standard tag systems are under development.